Midwest Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Midwest Trust's BMY Position: Q2 2026 in Review
Midwest Trust increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, buying an estimated $110K and bringing the position to 118,188 shares worth $6.81M. The position accounts for 0.08% of the portfolio, ranked #186.
Midwest Trust first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.05M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Midwest Trust held 118,188 shares of Bristol-Myers Squibb worth $6.81M as of Q2 2026.
- Midwest Trust bought 1,922 Bristol-Myers Squibb shares in Q2 2026, an estimated $110K.
- Bristol-Myers Squibb made up 0.08% of Midwest Trust's portfolio in Q2 2026, its #186 holding.
- Midwest Trust first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- Midwest Trust's Bristol-Myers Squibb position peaked at $7.05M in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.